Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan
(NASDAQ: ACRS) Delayed: 4.84 +0.34 (7.56%)
Previous Close $4.50    52 Week High $33.88 
Open $4.55    52 Week Low $14.12 
Day High $4.93    P/E N/A 
Day Low $4.50    EPS $0.00 
Volume 1,819,281